Press release

Category
Showing 1-16 of 21 results
Filter
  • Inceptua
  • Posted by Inceptua
26/08/2026
4 min read

Inceptua Group Selected to Manage TikoMed’s Named Patient Program for Investigational Therapy ILB® in Amyotrophic Lateral Sclerosis (ALS)

Windsor, London, UK, 26th August 2026. Inceptua Group...

Read More
  • Inceptua
  • Posted by Inceptua
23/02/2026
3 min read

Inceptua Group Appoints Healthcare Industry Leader Kurt Hilzinger as Chairman of the Board

LUXEMBOURG & NEW YORK – Inceptua Group, a...

Read More
  • Inceptua
  • Posted by Inceptua
09/01/2026
6 min read

Cycle Pharmaceuticals and Inceptua Group Expand the Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to Include Morocco and Egypt

Cycle Pharmaceuticals and Inceptua Group Expand the Free...

Read More
  • Inceptua
  • Posted by Inceptua
10/04/2025
2 min read

Inceptua Achieves Platinum Rating in 2025 EcoVadis Sustainability Assessment

Inceptua Achieves Platinum Rating in 2025 EcoVadis Sustainability...

Read More
  • Inceptua
  • Posted by Inceptua
15/05/2024
5 min read

Inceptua Group Expands Early Access Program to Latin America

Inceptua Group Expands Early Access Program to Latin...

Read More
  • Inceptua
  • Posted by Inceptua
18/01/2024
5 min read

Cycle Pharmaceuticals and Inceptua Group Partner for a Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU)

Cycle Pharmaceuticals Ltd (Cycle) and Inceptua Group (Inceptua)...

Read More
  • Inceptua
  • Posted by Inceptua
11/10/2022
7 min read

Inceptua Early Access and Sentynl Therapeutics Inc. Announce the Launch of the Early Access Program for Nulibry® (fosdenopterin)

Inceptua Early Access and Sentynl Therapeutics Inc. Announce...

Read More
  • Inceptua
  • Posted by Inceptua
05/10/2021
4 min read

Inceptua strengthens early access division with key business development hire

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
28/12/2020
2 min read

Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
03/12/2020
4 min read

Inceptua Partners with Global Blood Therapeutics for an Early Access Program for Voxelotor for Patients with Sickle Cell Disease

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

CONTINUE